ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

149 hedge funds and large institutions have $1.25B invested in Intra-Cellular Therapies Inc. in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 22 closing their positions.

Holders
149
Holders Change
+10
Holders Change %
+7.19%
% of All Funds
3.06%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
33
Increased
60
Reduced
32
Closed
22
Calls
$91M
Puts
$41.1M
Net Calls
+$49.8M
Net Calls Change
+$46.6M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$219M
2
WA
2
Wasatch Advisors
Utah
$94M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$33.8M
4
BlackRock
4
BlackRock
New York
$129M
5
PA
5
Pinnacle Associates
New York
$7.08M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$0
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$24.7M
3
CS
3
Candriam SCA
Luxembourg
$14.6M
4
Millennium Management
4
Millennium Management
New York
$4.82M
5
IC
5
Ikarian Capital
Texas
$185K
Name Market Value Shares Shares
Change 		Shares
Change %
SFM
176
Sphera Funds Management
Israel
– – – –
LDFR
177
Lehman & Derafelo Financial Resources
Pennsylvania
– – – –
CFGS
178
Concourse Financial Group Securities
Alabama
– – – –
4 5 6 7
8